Case for stopping targeted therapy when lung cancer progresses on treatment in hospice- eligible patients

Thomas J. Smith, Nasser Hanna, David Johnson, Sherman Baker, William A. Biermann, Julie Brahmer, Peter M. Ellis, Giuseppe Giaccone, Paul J. Hesketh, Ishmael Jaiyesimi, Natasha B. Leighl, Gregory J. Riely, Joan H. Schiller, Bryan J. Schneider, Joan Tashbar, Sarah Temin, Gregory Masters

Research output: Contribution to journalReview article

1 Scopus citations
Original languageEnglish (US)
Pages (from-to)780-783
Number of pages4
JournalJournal of Oncology Practice
Volume13
Issue number12
DOIs
StatePublished - Dec 2017

ASJC Scopus subject areas

  • Oncology
  • Oncology(nursing)
  • Health Policy

Cite this

Smith, T. J., Hanna, N., Johnson, D., Baker, S., Biermann, W. A., Brahmer, J., Ellis, P. M., Giaccone, G., Hesketh, P. J., Jaiyesimi, I., Leighl, N. B., Riely, G. J., Schiller, J. H., Schneider, B. J., Tashbar, J., Temin, S., & Masters, G. (2017). Case for stopping targeted therapy when lung cancer progresses on treatment in hospice- eligible patients. Journal of Oncology Practice, 13(12), 780-783. https://doi.org/10.1200/JOP.2017.027367